Mutual Influences between Nitric Oxide and Paraoxonase 1

New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease

(2019) Andreas Daiber et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes

(2018) Alena Viktorinova et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Paraoxonases: metabolic role and pharmacological projection

(2018) Carlos Moya et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses

(2018) Michael Maes et al.   NEUROTOXICITY RESEARCH

Paraoxonase 1 in endothelial cells impairs vasodilation induced by arachidonic acid lactone metabolite

(2018) Dan Gilad et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Cardiovascular risk and the effect of nitric oxide synthase inhibition in female rats: The role of estrogen

(2017) Jaqueline C. Castardo-de-Paula et al.   EXPERIMENTAL GERONTOLOGY

Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis

(2016) J. Rodriguez-Carrio et al.   CLINICAL SCIENCE

5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1

(2015) Suzy Eryanni-Levin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Hyperhomocysteinemia: a missing link to dysfunctional HDL via paraoxanase-1

(2015) Srikanth Givvimani et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality

(2015) Ki-Chul Sung et al.   HEART

Structural and functional changes in HDL with low grade and chronic inflammation

(2015) Francis O'Neill et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction

(2015) Xiaodong Gu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Walk-Run Training Improves the Anti-Inflammation Properties of High-Density Lipoprotein in Patients With Metabolic Syndrome

(2015) Hui Sang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome

(2015) Paul R. J. Ames et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The effects of atorvastatin on antioxidant/antiinflammatory propertiesof HDLs in hypercholesterolemics

(2015) Gülşen AKALIN ÇİFTÇİ et al.   Turkish Journal Of Medical Sciences

The synthesis and analysis of S-nitorsylated paraoxonase 1

(2014) Soliman Khatib et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease

(2014) A. Kratzer et al.   CARDIOVASCULAR RESEARCH

Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review

(2014) David Abelló et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome

(2013) Monica Gomaraschi et al.   CARDIOVASCULAR RESEARCH

Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease

(2013) Huige Li et al.   CURRENT OPINION IN PHARMACOLOGY

Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2

(2013) Thimoteus Speer et al.   IMMUNITY

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

(2013) Ying Huang et al.   JOURNAL OF CLINICAL INVESTIGATION

The effects of atorvastatin on oxidative stress in L-NAME-treated rats

(2013) Volkan Sozer et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Oxidative stress in vascular disease and its pharmacological prevention

(2013) Huige Li et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Paraoxonase 1 and homocysteine metabolism

(2012) Joanna Perła-Kaján et al.   AMINO ACIDS

State of the art paper Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases

(2012) Necat Yilmaz   Archives of Medical Science

Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid

(2012) Aviva Gamliel-Lazarovich et al.   ATHEROSCLEROSIS

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

(2012) Suowen Xu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Protection of DDAH2 Overexpression Against Homocysteine-Induced Impairments of DDAH/ADMA/NOS/NO Pathway in Endothelial Cells

(2012) Li-Hua Liu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Subcellular Localization of Oxidants and Redox Modulation of Endothelial Nitric Oxide Synthase

(2012) Bradley A. Maron et al.   CIRCULATION JOURNAL

Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS

(2012) Tulin Bayrak et al.   GYNECOLOGICAL ENDOCRINOLOGY

Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction

(2012) Fahri Bayram et al.   GYNECOLOGICAL ENDOCRINOLOGY

Cutting Edge: Nitric Oxide Inhibits the NLRP3 Inflammasome

(2012) E. Hernandez-Cuellar et al.   JOURNAL OF IMMUNOLOGY

Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β

(2012) Bibhuti B Mishra et al.   NATURE IMMUNOLOGY

Oxidized Low-Density Lipoprotein Activates p66 Shc via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Protein Kinase C-β, and c-Jun N-Terminal Kinase Kinase in Human Endothelial Cells

(2011) Yi Shi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Nitric oxide synthases: regulation and function

(2011) U. Forstermann et al.   EUROPEAN HEART JOURNAL

Malondialdehyde-modified LDL to HDL-cholesterol ratio reflects endothelial damage

(2011) Tomonori Sugiura et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

PON-dering differences in HDL function in coronary artery disease

(2011) Chieko Mineo et al.   JOURNAL OF CLINICAL INVESTIGATION

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells

(2010) Xiao-mei Bao et al.   ACTA PHARMACOLOGICA SINICA

Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression

(2010) Syed Ahmad et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hormonal modulation of endothelial NO production

(2010) Sue P. Duckles et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy

(2009) Sajoscha A. Sorrentino et al.   CIRCULATION

Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

(2009) Marietta Charakida   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes

(2008) Gu Weijun et al.   ADVANCES IN THERAPY

Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice

(2008) Soumi Kundu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY